Runlin Shi
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Bioactive Compounds and Antitumor Agents
Papers in
-
- Epigenetics and DNA Methylation 2
- Circular RNAs in diseases 2
- Bioactive Natural Diterpenoids Research 1
-
- MicroRNA in disease regulation 3
- Cancer-related molecular mechanisms research 3
- Cancer Genomics and Diagnostics 1
- Cancer, Hypoxia, and Metabolism 1
- Co-authors
- Hua Xu (4 shared papers)Zhangqun Ye (3 shared papers)Tao Yang (3 shared papers)Lei Chang (3 shared papers)Yu Gan (2 shared papers)Ke Chen (2 shared papers)Haibing Xiao (2 shared papers)Bin Lang (2 shared papers)
In The Last Decade
Runlin Shi
8 papers receiving 188 citations
Peers
Comparison fields: 5 of 47
- Cancer Research 86
- Toxicology 11
- Molecular Biology 130
- Oncology 30
- Pharmacology 9
Countries citing papers authored by Runlin Shi
This map shows the geographic impact of Runlin Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Runlin Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Runlin Shi more than expected).
Fields of papers citing papers by Runlin Shi
This network shows the impact of papers produced by Runlin Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Runlin Shi. The network helps show where Runlin Shi may publish in the future.
Co-authors
The 25 scholars most cited alongside Runlin Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 55 | |
| 2 | 2014 | 53 | |
| 3 | 2014 | 20 | |
| 4 | 2021 | 18 | |
| 5 | 2013 | 15 | |
| 6 | 2022 | 14 | |
| 7 | 2005 | 13 | |
| 8 | 2025 | 1 | |
| 9 | 2024 | 0 |
About Runlin Shi
Runlin Shi is a scholar working on Molecular Biology, Cancer Research, Surgery, Pulmonary and Respiratory Medicine and Oncology, having authored 9 papers that have together received 189 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (3 papers), Cancer-related molecular mechanisms research (3 papers), Epigenetics and DNA Methylation (2 papers), Circular RNAs in diseases (2 papers), Renal cell carcinoma treatment (2 papers), Cancer Genomics and Diagnostics (1 paper), Bioactive Natural Diterpenoids Research (1 paper) and Cancer, Hypoxia, and Metabolism (1 paper). The work is most often cited by research in Cancer Research (86 citations), Toxicology (11 citations), Molecular Biology (130 citations), Oncology (30 citations) and Pharmacology (9 citations). Runlin Shi has collaborated with scholars based in China, Macao and Germany. Frequent co-authors include Hua Xu, Zhangqun Ye, Tao Yang, Lei Chang, Yu Gan, Ke Chen, Haibing Xiao, Bin Lang, Yonglian Guo and Wei He. Their work appears in journals such as Journal of Experimental & Clinical Cancer Research, Cancers, Frontiers of Medicine, International Journal of Surgery and Frontiers in Molecular Biosciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.